verapamil has been researched along with chloroquine in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (13.04) | 18.7374 |
1990's | 39 (33.91) | 18.2507 |
2000's | 31 (26.96) | 29.6817 |
2010's | 30 (26.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Alibert, S; Barbe, J; Houdoin, C; Karolak-Wojciechowska, J; Parzy, D; Pradines, B; Santelli-Rouvier, C | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Cooper, RA; Dodean, RA; Hinrichs, DJ; Janowsky, A; Johnson, RA; Kelly, JX; Lane, KD; Riscoe, M; Smilkstein, MJ; Winter, R | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
Pratim Roy, P; Roy, K | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Masseno, V; Muriithi, S; Nzila, A | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Sen, S; Sinha, N | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Fujii, H; Kobayashi, S; Miyata, Y; Nagase, H; Osa, Y; Takeuchi, T | 1 |
Bettis, S; Brun, R; Fomovska, A; Huang, Q; Kaiser, M; Kozikowski, AP; McLeod, R; Mui, E; Pieroni, M; Stec, J; Witola, WH | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Basilico, N; Bernetti, M; Bonache de Marcos, MC; Brogi, S; Brun, R; Butini, S; Caccia, S; Camodeca, C; Campiani, G; Gemma, S; Gorelli, B; Guiso, G; Joshi, BP; Lamponi, S; Martin, RE; Moretti, V; Novellino, E; Parapini, S; Rottmann, M; Sanna Coccone, S; Saponara, S; Savini, L; Summers, RL; Taramelli, D | 1 |
Bartolommei, G; Basilico, N; Brindisi, M; Brogi, S; Butini, S; Camodeca, C; Campiani, G; Fiorini, I; Gabellieri, E; Gemma, S; Gualdani, R; Habluetzel, A; Kukreja, G; Kunjir, S; Lamponi, S; Lucantoni, L; Martin, RE; Moncelli, MR; Novellino, E; Savini, L; Summers, RL; Tadini-Buoninsegni, F; Taramelli, D; Valoti, M | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Kong, LY; Lan, JS; Li, SY; Pan, LF; Wang, XB; Xie, SS | 1 |
Joubert, J; Kapp, E; Malan, SF; Smith, PJ; Taylor, D | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cai, P; Kong, LY; Li, F; Wang, J; Wang, XB; Wu, JJ; Yang, XL | 1 |
Chibale, K; Egan, TJ; Hunter, R; Joshi, MC; Ndove, J; Nsumiwa, S; Okombo, J; Taylor, D; Wiesner, L | 1 |
Aguiar, ACC; Correia, CRD; Costa, JL; de Souza, GE; Garcia, CRS; Garcia, ML; Guido, RVC; Nakabashi, M; Oliva, G; Panciera, M; Simão Dos Santos, EF; Singh, MK | 1 |
Cheuka, PM; Chibale, K; Lawrence, N; Taylor, D; Wittlin, S | 1 |
Daniel, JC; Lecerf, JM; Levy, SB; Slapak, CA | 1 |
Barnes, DA; Cowman, AF; Foote, SJ; Galatis, D; Kemp, DJ | 1 |
Bray, PG; Howells, RE; Ritchie, GY; Ward, SA | 1 |
Bhambhani, S; Biswas, S; Dewan, S; Valecha, N | 1 |
Bass, GT; Gerena, L; Kyle, DE; Martin, RK; Milhous, WK; Oduola, AM | 1 |
Kimata, I; Miki, A; Ohsawa, K; Tanabe, K | 1 |
do Rosario, VE; Gluzman, IY; Gwadz, RW; Krogstad, DJ; Panton, LJ; Walker-Jonah, A; Wellems, TE | 1 |
Bolívar, JJ; Cereijido, M; Chávez De Ramirez, B; Contreras, RG; Gonzalez-Mariscal, L; Ponce, A | 1 |
Baguley, BC; Ferguson, LR; Turner, PM | 1 |
Gluzman, IY; Krogstad, DJ; Martin, JT; Nkangineme, K; Orjih, AU; Schlesinger, PH; Wellems, TE | 1 |
Bazill, GW; Dexter, TM | 1 |
Anderson, SK; DeSantes, K; Geissler, F; Press, OW | 1 |
Cutler, DJ; Ferrari, V | 1 |
Doi, S; Hagiwara, A; Izumo, A; Kato, M; Tanabe, K | 1 |
Van Dyke, K; Ye, ZG | 1 |
Broxterman, HJ; Kuiper, CM; Lankelma, J; Pinedo, HM; Schuurhuis, GJ | 1 |
Safa, AR; Spearman, T; Van Dyke, K; Ye, ZG | 1 |
Fitch, CD | 1 |
Beck, WT; Cirtain, MC; Danks, MK; Felsted, RL; Safa, AR; Suttle, DP; Trent, JM; Wolverton, JS | 1 |
Beck, WT; Cirtain, MC; Felsted, RL; Glover, CJ; Safa, AR | 1 |
Aikawa, M; Jacobs, GH; Kyle, DE; Martin, SK; Milhous, WK; Oduola, AM | 1 |
Beck, WT; Pearce, HL; Zamora, JM | 1 |
Rosén, A; Szigeti, R | 1 |
Brockelman, CR; Bunnag, D; Satayavivad, J; Tan-ariya, P; Wongsawatkul, O | 1 |
Martin, SK; Milhous, WK; Oduola, AM | 1 |
Drevon, CA; Nossen, JO; Rustan, AC; Tefre, T | 1 |
Akiyama, S; Kuwano, M; Tomita, K | 1 |
Akiyama, S | 1 |
Clark, JS; Jubb, SN; Maloney, PJ; Young, JM | 1 |
Chu, F; Cowman, AF; Gros, P; Karcz, S; Schurr, E; van Es, HH; Vidal, S | 1 |
Bray, PG; Hawley, SR; Mungthin, M; Ward, SA | 1 |
Cerami, A; Martiney, JA; Slater, AF | 1 |
Chong, AS; Coon, JS; Gebel, HM; Markham, PN | 1 |
Arnot, DE; Babiker, HA; Bayoumi, RA | 1 |
Hess, FI; Kilian, A; Löscher, T; Nothdurft, HD; Pröll, S; Söllner, W | 1 |
Boulter, MK; Bray, PG; Howells, RE; Ritchie, GY; Ward, SA | 1 |
Bhaduri, AP; De, D; Milhous, WK | 1 |
Kyle, DE; Milhous, WK; Rossan, RN | 1 |
Marcil, J; Ravindranath, N; Sairam, MR | 1 |
Arnot, DE; Sohal, AK | 1 |
Borg, TK; Samarel, AM; Sharp, WW; Terracio, L | 1 |
Bhaduri, AP; Seth, M; Walter, RD | 1 |
Balkenende, AY; Slaper-Cortenbach, IC; van den Berg, H; van der Schoot, CE; Van Leeuwen, EF; Vervoordeldonk, SF; von dem Borne, AE | 1 |
Bray, PG; Hawley, SR; Naisbitt, DJ; O'Neill, PM; Park, BK; Ward, SA | 1 |
Chung, R; Cowman, AF; Foley, M; Riffkin, CD; Tilley, L; Wall, DM; Zalcberg, JR | 1 |
Bray, PG; Green, JE; Hawley, SR; Mungthin, M; Ritchie, GY; Ward, SA | 1 |
Arttamangkul, S; Poot, M | 1 |
Balogh, Z; Fóris, G; Keresztes, T; Kovács, E; Leövey, A; Paragh, G; Szabolcs, M | 1 |
Adovelande, J; Delèze, J; Schrével, J | 1 |
Mangou, F; Platel, DF; Tribouley-Duret, J | 1 |
Ayesh, S; Litman, T; Stein, WD | 1 |
Boyer, JL; Hayes, JH; Rios-Velez, L; Soroka, CJ | 1 |
Bray, PG; Ginsburg, H; Janneh, O; Mungthin, M; Raynes, KJ; Ward, SA | 1 |
Bray, PG; Mungthin, M; Ward, SA | 1 |
Frappier, F; Rafatro, H; Rakoto-Ratsimamanga, A; Ramanitrahasimbola, D; Rasoanaivo, P; Ratsimamanga-Urverg, S | 1 |
Caruana, SR; Cowman, AF; Kirk, K; Reed, MB; Saliba, KJ | 1 |
Dzekunov, SM; Roepe, PD; Ursos, LM | 1 |
Cooper, RA; Deitsch, KW; Dzekunov, SM; Ferdig, MT; Fidock, DA; Naudé, B; Nomura, T; Roepe, PD; Sidhu, AB; Su, XZ; Talley, AK; Ursos, LM; Wellems, TE; Wootton, JC | 1 |
Cooper, RA; Ferdig, MT; Fidock, DA; Fujioka, H; Mu, J; Nomura, T; Roepe, PD; Su, XZ; Ursos, LM; Wellems, TE | 1 |
Fidock, DA; Sidhu, AB; Verdier-Pinard, D | 1 |
Baker, J; Chen, N; Cheng, Q; Fowler, EV; Kyle, DE; Pasay, C; Peters, JM | 1 |
Warhurst, DC | 1 |
Bennett, TN; Dzekunov, S; Fidock, DA; Kosar, AD; Roepe, PD; Singh Sidhu, AB; Ursos, LM | 1 |
Bray, PG; Fidock, DA; Johnson, DJ; Lakshmanan, V; Mungthin, M; Sidhu, AB; Ward, SA | 1 |
Lanzer, M; McLean, JE; Sanchez, CP; Stein, W | 1 |
Hayward, R; Kirk, K; Saliba, KJ | 1 |
Lantvit, D; Lim, E; Pezzuto, JM; Tamez, PA | 1 |
Alakpa, GE; Bray, PG; Fidock, DA; Horrocks, P; Hughes, RH; Johnson, DJ; Krogstad, DJ; Lakshmanan, V; Muhle, RA; Sidhu, AB; Verdier-Pinard, D; Ward, SA | 1 |
Gbotosho, GO; Gerena, L; Happi, CT; Kyle, DE; Milhous, WK; Oduola, AM; Ogundahunsi, OA; Salako, LA; Sowunmi, A | 1 |
Hayward, R; Kirk, K; Lehane, AM; Saliba, KJ | 1 |
Bröer, S; Cowan, AI; Howitt, SM; Kirk, K; Marchetti, RV; Martin, RE | 1 |
Checkley, L; Cooper, RA; Deng, B; Ferdig, MT; Gonzales, JM; Patel, JJ; Pleeter, P; Roepe, PD; Tan, JC; Thacker, D | 1 |
Chen, MJ; Cheu, KW; Coghi, P; Guo, ZF; Guo, ZH; Haynes, RK; Li, KY; Monti, D; Tang, MM; Wong, HN | 1 |
Papakrivos, J; Sá, JM; Wellems, TE | 1 |
Choi, AR; Kim, JH; Kim, YK; Yoon, S | 1 |
Chan, KW; Chow, LM; Choy, KY; Lear, MJ; Lee, YQ; Loh, CC; Nosten, FH; Rénia, L; Russell, B; Suwanarusk, R; Tan, KS | 1 |
Bellanca, S; Dave, A; Dittmer, M; Lanzer, M; Martin, RE; Meyrath, M; Nash, MN; Sanchez, CP; Stein, WD; Summers, RL | 1 |
Enomoto, M; Furuyama, W; Kawai, S; Kawazu, S; Mikoshiba, K; Mossaad, E | 1 |
Fukui, T; Iwai, H; Juge, N; Kawakami, M; Miyaji, T; Moriyama, S; Moriyama, Y; Nelson, N; Omote, H | 1 |
Kania, E; Litwiniuk, A; O'Prey, J; Orzechowski, A; Pająk, B; Ryan, KM; Sierra Gonzalez, P; Urbańska, K | 1 |
Ariey, F; Dhingra, SK; Fairhurst, RM; Fidock, DA; Kümpornsin, K; Menard, D; Mok, S; Ross, LS; Takala-Harrison, S; Wicht, KJ; Witkowski, B; Yeo, T | 1 |
3 review(s) available for verapamil and chloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Ferriprotoporphyrin IX: role in chloroquine susceptibility and resistance in malaria.
Topics: Animals; Chloroquine; Drug Resistance; Erythrocytes; Heme; Hemin; Hemoglobins; Malaria; Plasmodium; Verapamil | 1989 |
[Intracellular signal transmission of low density lipoprotein receptors in human monocytes].
Topics: Calcium Channel Blockers; Chloroquine; Cholesterol; Humans; Lipoproteins, LDL; Monocytes; Phospholipases; Protein Kinase C; Receptors, LDL; Verapamil | 1997 |
112 other study(ies) available for verapamil and chloroquine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Synthesis and effects on chloroquine susceptibility in Plasmodium falciparum of a series of new dihydroanthracene derivatives.
Topics: Animals; Anthracenes; Antimalarials; Chloroquine; CHO Cells; Cricetinae; Drug Resistance, Multiple; Erythrocytes; In Vitro Techniques; Models, Molecular; Plasmodium falciparum; Structure-Activity Relationship | 2002 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.
Topics: Acridones; Animals; Antimalarials; Cell Survival; Cells, Cultured; Drug Design; Drug Interactions; Drug Resistance, Multiple; Lymphocytes; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Molecular Structure; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Structure-Activity Relationship | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results | 2009 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid.
Topics: Adjuvants, Pharmaceutic; Animals; Antimalarials; Parasitic Sensitivity Tests; Plasmodium falciparum; Probenecid; Verapamil | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Opioid δ₁ receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi.
Topics: Antimalarials; Benzylidene Compounds; Chloroquine; Drug Resistance; Molecular Structure; Naltrexone; Parasitic Sensitivity Tests; Plasmodium chabaudi; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship | 2011 |
Synthesis, biological evaluation, and structure-activity relationships of N-benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), Trypanosomes, and Leishmania.
Topics: Antimalarials; Benzamides; Imides; Leishmania donovani; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling.
Topics: Aminoquinolines; Animals; Antimalarials; Biological Transport; Cell Line; Chloroquine; Clotrimazole; Drug Resistance; Female; Half-Life; Hemeproteins; Humans; Malaria; Male; Membrane Transport Proteins; Mice; Models, Molecular; Mutation; Oocytes; Piperazines; Plasmodium berghei; Plasmodium falciparum; Protozoan Proteins; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Ventricular Pressure; Xenopus laevis | 2012 |
Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents.
Topics: Animals; Antimalarials; Benzoxazines; Cell Line; Humans; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Mice; Models, Molecular; Molecular Mimicry; Quinazolines; Spectrometry, Mass, Electrospray Ionization | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Carbolines; Cell Line; Chelating Agents; Cholinesterase Inhibitors; Drug Design; Electrophorus; Horses; Humans; Molecular Docking Simulation; Protein Aggregation, Pathological; Tacrine | 2014 |
Polycyclic amines as chloroquine resistance modulating agents in Plasmodium falciparum.
Topics: Adamantane; Amines; Animals; Antimalarials; Calcium Channels; Cell Survival; Chloroquine; CHO Cells; Cricetinae; Cricetulus; Drug Resistance; Inhibitory Concentration 50; Plasmodium falciparum; Protein Binding; Structure-Activity Relationship | 2016 |
Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Benzylamines; Blood-Retinal Barrier; Butyrylcholinesterase; Cell Death; Cholinergic Agents; Cholinesterase Inhibitors; Cinnamates; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Rats; Structure-Activity Relationship | 2017 |
4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice.
Topics: Administration, Oral; Aminopyridines; Aminoquinolines; Animals; Antimalarials; Cell Membrane Permeability; Chloroquine; CHO Cells; Cricetulus; Drug Evaluation, Preclinical; Drug Resistance, Microbial; ERG1 Potassium Channel; Hemeproteins; Humans; Malaria; Male; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum; Solubility; Structure-Activity Relationship | 2017 |
Discovery of Marinoquinolines as Potent and Fast-Acting Plasmodium falciparum Inhibitors with in Vivo Activity.
Topics: Animals; Antimalarials; Drug Design; Mice; Models, Molecular; Molecular Conformation; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Quinolines | 2018 |
Antiplasmodial imidazopyridazines: structure-activity relationship studies lead to the identification of analogues with improved solubility and hERG profiles.
Topics: | 2018 |
Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Compartmentation; Chloroquine; Daunorubicin; Deoxyglucose; Dinitrophenols; Drug Interactions; Drug Resistance; Energy Metabolism; Ethylmaleimide; Humans; Leukemia; Membrane Glycoproteins; Methylamines; Microscopy, Fluorescence; Monensin; Ouabain; Sodium Azide; Tumor Cells, Cultured; Vanadates; Verapamil | 1992 |
Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Chromosome Deletion; Chromosome Mapping; Dose-Response Relationship, Drug; Drug Resistance; Gene Amplification; Mefloquine; Membrane Glycoproteins; Plasmodium falciparum; Restriction Mapping; Verapamil | 1992 |
Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. A correlation of chloroquine sensitivity with energy-dependent drug accumulation.
Topics: Animals; Chloroquine; Drug Resistance; Hydrogen-Ion Concentration; Plasmodium falciparum; Time Factors; Verapamil | 1992 |
Reversal of chloroquine resistance with verapamil in P. berghei in vivo.
Topics: Animals; Chloroquine; Drug Resistance; Mice; Plasmodium berghei; Verapamil | 1992 |
Fluoxetine hydrochloride enhances in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.
Topics: Animals; Chloroquine; Drug Resistance, Microbial; Drug Synergism; Fluoxetine; Microbial Sensitivity Tests; Phenotype; Plasmodium falciparum; Verapamil | 1992 |
Ultrastructural changes associated with reversal of chloroquine resistance by verapamil in Plasmodium chabaudi.
Topics: Animals; Chloroquine; Cytoplasm; Drug Interactions; Drug Resistance; Endoplasmic Reticulum; Female; Malaria; Mice; Microscopy, Electron; Plasmodium chabaudi; Vacuoles; Verapamil | 1991 |
Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chloroquine; Crosses, Genetic; Drug Resistance; Gene Amplification; Genes; Membrane Glycoproteins; Molecular Sequence Data; Oligonucleotide Probes; Phenotype; Plasmodium falciparum; Verapamil | 1990 |
Role of calcium in tight junction formation between epithelial cells.
Topics: Affinity Labels; Animals; Calcium; Calcium Channel Blockers; Cell Line; Chloroquine; Cytosol; Egtazic Acid; Electric Conductivity; Epithelium; Gallic Acid; Indoles; Intercellular Junctions; Kinetics; Mannitol; Microscopy, Electron; Microscopy, Electron, Scanning; Verapamil | 1990 |
Protection by inhibitors of multidrug resistance against mitochondrial mutagenesis in Saccharomyces cerevisiae.
Topics: Aminoacridines; Chloroquine; Drug Resistance; Mitochondria; Mutagens; Mutation; Polysorbates; Saccharomyces cerevisiae; Verapamil | 1990 |
A rapid in vitro test for chloroquine-resistant Plasmodium falciparum.
Topics: Animals; Anticoagulants; Cells, Cultured; Chloroquine; Drug Resistance; Erythrocytes; Leukocytes; Plasmodium falciparum; Predictive Value of Tests; Temperature; Verapamil | 1990 |
Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Survival; Chloroquine; Diltiazem; Drug Synergism; Endocytosis; Furans; Humans; Hydroxyzine; In Vitro Techniques; Leukemia, Myeloid; Mice; Nifedipine; Phospholipid Ethers; Platelet Activating Factor; Pyridines; Quinidine; Quinine; Sodium Fluoride; Thiazoles; Triazoles; Verapamil | 1990 |
Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores.
Topics: Acid Phosphatase; Amantadine; Ammonium Chloride; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Chloroquine; Chromatography, High Pressure Liquid; Humans; Iodine Radioisotopes; Lysosomes; Mice; Monensin; Nigericin; Temperature; Tumor Cells, Cultured; Verapamil | 1990 |
Uptake of chloroquine by human erythrocytes.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amino Acids; Biological Transport; Blood Glucose; Carrier Proteins; Chloroquine; Choline; Diffusion; Erythrocyte Membrane; Erythrocytes; Humans; Hydrogen-Ion Concentration; Kinetics; Membrane Potentials; Nucleosides; Verapamil | 1990 |
Plasmodium chabaudi: in vivo effects of Ca2+ antagonists on chloroquine-resistant and chloroquine-sensitive parasites.
Topics: Animals; Calcium Channel Blockers; Chloroquine; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Malaria; Mice; Mice, Inbred ICR; Nicardipine; Plasmodium; Verapamil | 1990 |
Reversal of chloroquine resistance in falciparum malaria independent of calcium channels.
Topics: Animals; Calcium; Chloroquine; Drug Interactions; Drug Resistance; Gallopamil; Ion Channels; Malaria; Plasmodium falciparum; Verapamil | 1988 |
Glycolysis in P-glycoprotein-overexpressing human tumor cell lines. Effects of resistance-modifying agents.
Topics: Adenosine Triphosphate; Amiloride; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Proteins; Chloroquine; Cytochalasin B; Drug Resistance; Energy Metabolism; Glutathione Transferase; Glycolysis; Humans; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Membrane Glycoproteins; Monensin; Nigericin; Oxygen Consumption; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Verapamil | 1989 |
3H-azidopine photoaffinity labeling of high molecular weight proteins in chloroquine resistant falciparum malaria.
Topics: Affinity Labels; Animals; Azides; Binding, Competitive; Chloroquine; Chlorpromazine; Dihydropyridines; Drug Resistance; Glycoproteins; Molecular Weight; Nicardipine; Photochemistry; Plasmodium falciparum; Proteins; Quinacrine; Reserpine; Trifluoperazine; Verapamil | 1989 |
Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Chromosome Banding; Chromosomes, Human, Pair 13; Colchicine; Dactinomycin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia; Membrane Glycoproteins; Molecular Weight; Podophyllotoxin; Teniposide; Tumor Cells, Cultured; Verapamil; Vinblastine; Vinca Alkaloids | 1987 |
Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
Topics: Affinity Labels; Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Survival; Chloroquine; Drug Interactions; Drug Resistance; Humans; Indoles; Leukemia; Membrane Glycoproteins; Photochemistry; Quinacrine; Quinine; Reserpine; Verapamil; Vinblastine; Vinca Alkaloids; Vindesine; Yohimbine | 1988 |
Ultrastructural study of the effects of chloroquine and verapamil on Plasmodium falciparum.
Topics: Animals; Chloroquine; Drug Interactions; Drug Resistance; Microscopy, Electron; Plasmodium falciparum; Vacuoles; Verapamil | 1988 |
Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry, Physical; Chloroquine; Computer Simulation; Doxorubicin; Drug Resistance; Humans; Leukemia; Naphthacenes; Podophyllotoxin; Quinacrine; Verapamil; Vinca Alkaloids | 1988 |
Studies on leukocyte migration inhibitory factor (LIF) produced by activated T and B cells.
Topics: B-Lymphocytes; Chloroquine; Humans; In Vitro Techniques; Kinetics; Leukocyte Migration-Inhibitory Factors; Lymphocyte Activation; Lymphokines; Molecular Weight; Polymyxin B; T-Lymphocytes; Verapamil | 1988 |
Flunarizine and verapamil inhibit chloroquine-resistant Plasmodium falciparum growth in vitro.
Topics: Animals; Antimalarials; Chloroquine; Chlorpromazine; Drug Resistance; Flunarizine; Mefloquine; Plasmodium falciparum; Quinine; Quinolines; Regression Analysis; Verapamil | 1987 |
Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.
Topics: Animals; Biological Transport; Chloroquine; Drug Resistance; Drug Synergism; Plasmodium falciparum; Verapamil | 1987 |
Inhibition of very-low-density lipoprotein secretion by chloroquine, verapamil and monensin takes place in the Golgi complex.
Topics: Animals; Chloroquine; Golgi Apparatus; Kinetics; Lipoproteins, VLDL; Liver; Male; Mathematics; Microscopy, Electron; Models, Biological; Monensin; Rats; Verapamil | 1987 |
The effect of calcium antagonists on the proteolytic degradation of low-density lipoprotein in HeLa cells.
Topics: Calcium Channel Blockers; Cell Compartmentation; Chloroquine; Cholesterol; Endocytosis; Female; Gallopamil; HeLa Cells; Humans; Kinetics; Lipoproteins, LDL; Lysosomes; Peptide Hydrolases; Verapamil | 1985 |
[The effect of calcium antagonists on intracellular transport of epidermal growth factor and the conjugate of epidermal growth factor with pseudomonas exotoxin].
Topics: Biological Transport; Calcium Channel Blockers; Cathepsin B; Cathepsins; Cell Line; Cell Survival; Cells, Cultured; Chloroquine; Endotoxins; Enzyme Activation; Epidermal Growth Factor; Gallopamil; Humans; Lysosomes; Neoplasms, Experimental; Nifedipine; Pseudomonas aeruginosa; Verapamil | 1985 |
Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse.
Topics: Anaphylaxis; Animals; Chloroquine; Chlortetracycline; Dexamethasone; Dose-Response Relationship, Drug; Female; Indomethacin; Injections, Intravenous; Male; Mice; Mice, Inbred DBA; Naproxen; Nicardipine; Nifedipine; Platelet Activating Factor; Pyrazoles; Quinacrine; Tetracycline; Verapamil | 1985 |
Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine.
Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Base Sequence; Biological Transport; Cell Survival; Chloroquine; CHO Cells; Colchicine; Cricetinae; Cystic Fibrosis Transmembrane Conductance Regulator; DNA, Protozoan; Doxorubicin; Drug Resistance; Female; Gene Expression; Genes, Protozoan; Membrane Proteins; Oligonucleotides, Antisense; Oocytes; Plasmodium falciparum; Primaquine; Protozoan Proteins; Quinine; Restriction Mapping; Verapamil; Vinblastine; Xenopus laevis | 1994 |
Current views on the mechanisms of resistance to quinoline-containing drugs in Plasmodium falciparum.
Topics: Animals; Antimalarials; Biological Transport; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Phenanthrenes; Plasmodium falciparum; Verapamil | 1995 |
Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect.
Topics: Animals; Biological Transport; Chloroquine; Drug Resistance; Erythrocytes; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Plasmodium falciparum; Structure-Activity Relationship; Verapamil | 1995 |
Natural killer cell cytotoxicity and the multidrug resistance gene.
Topics: CD8 Antigens; Chloroquine; Cyclosporine; Cytotoxicity, Immunologic; DNA; Drug Resistance; Humans; Killer Cells, Natural; Membrane Glycoproteins; Perforin; Polyethylene Glycols; Polymerase Chain Reaction; Pore Forming Cytotoxic Proteins; RNA; Stearic Acids; T-Lymphocytes, Cytotoxic; Verapamil | 1993 |
Uptake and efflux of chloroquine by chloroquine-resistant Plasmodium falciparum clones recently isolated in Africa.
Topics: Africa; Animals; Chloroquine; Desipramine; Drug Resistance; Erythrocytes; Plasmodium falciparum; Verapamil | 1994 |
Plasmodium falciparum and Plasmodium berghei: effect of magnesium on the development of parasitemia.
Topics: Analysis of Variance; Animals; Calcium; Chloroquine; Culture Media; Dose-Response Relationship, Drug; Drug Resistance; Erythrocytes; Female; Magnesium; Malaria; Mice; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Time Factors; Verapamil | 1995 |
Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum.
Topics: Animals; Biological Transport, Active; Chloroquine; Desipramine; Drug Resistance; Humans; Hydrogen-Ion Concentration; Kinetics; Malaria, Falciparum; Plasmodium falciparum; Verapamil | 1994 |
A novel pyrrolidonoalkaneamine (WR268954) that modulates chloroquine resistance of Plasmodium falciparum in vitro.
Topics: Animals; Anisoles; Antimalarials; Chloroquine; Drug Resistance; Drug Synergism; Molecular Structure; Plasmodium falciparum; Pyrrolidines; Quinine; Verapamil | 1993 |
Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys.
Topics: Animals; Aotus trivirgatus; Calcium Channel Blockers; Chloroquine; Chlorpromazine; Cyproheptadine; Disease Models, Animal; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Ketotifen; Malaria, Falciparum; Plasmodium falciparum; Prochlorperazine; Propylamines; Verapamil | 1993 |
Cytotoxic activity of lutropin-gelonin conjugate in mouse Leydig tumor cells: potentiation of the hormonotoxin activity by different drugs.
Topics: Animals; Antineoplastic Agents; Chloroquine; Drug Screening Assays, Antitumor; Drug Synergism; Leydig Cell Tumor; Leydig Cells; Luteinizing Hormone; Male; Mice; Monensin; Neoplasm Proteins; Plant Proteins; Progesterone; Protein Synthesis Inhibitors; Quinacrine; Receptors, LH; Ribosome Inactivating Proteins, Type 1; Testicular Neoplasms; Tumor Cells, Cultured; Verapamil | 1993 |
Plasmodium chabaudi: a short-term in vitro culture method and its application to chloroquine resistance testing.
Topics: Animals; Cells, Cultured; Chloroquine; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Erythrocytes; Mice; Plasmodium chabaudi; Verapamil | 1993 |
Contractile activity modulates actin synthesis and turnover in cultured neonatal rat heart cells.
Topics: Actins; Animals; Animals, Newborn; Cells, Cultured; Chloroquine; Membrane Potentials; Myocardial Contraction; Myocardium; Myofibrils; Rats; Sarcomeres; Tetradecanoylphorbol Acetate; Time Factors; Verapamil | 1993 |
Reversal of chloroquine resistance in Plasmodium falciparum by CDR 87/209 and analogues.
Topics: Animals; Chloroquine; Drug Interactions; Drug Resistance; Molecular Structure; Plasmodium falciparum; Pyrrolidines; Verapamil | 1993 |
Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; B-Lymphocytes; Biological Transport; Burkitt Lymphoma; Calcium Channel Blockers; Cell Adhesion Molecules; Chloroquine; Colchicine; Etoposide; Humans; Immunoglobulin Isotypes; Immunotoxins; Iodine Radioisotopes; Lectins; Leukemia, B-Cell; Mice; Monensin; Paclitaxel; Radioimmunotherapy; Receptors, IgG; Sialic Acid Binding Ig-like Lectin 2; Verapamil; Vinblastine; Vincristine | 1996 |
Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component.
Topics: Alkylation; Amodiaquine; Animals; Antimalarials; Calcium Channel Blockers; Cell Survival; Chemical Phenomena; Chemistry, Physical; Chloroquine; Drug Resistance; Glutathione; Humans; In Vitro Techniques; Leukocytes; Plasmodium falciparum; Verapamil | 1996 |
Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine.
Topics: Affinity Labels; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Biological Transport, Active; Chloroquine; Drug Interactions; Drug Resistance, Multiple; Fluorescent Dyes; Humans; Kinetics; Mefloquine; Neoplasms; Prazosin; Tumor Cells, Cultured; Verapamil; Vinblastine | 1996 |
In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1.
Topics: Animals; Antimalarials; ATP-Binding Cassette Transporters; Biological Transport; Chloroquine; DNA Fingerprinting; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Gene Dosage; Gene Expression; Immunoblotting; Mefloquine; Phenanthrenes; Plasmodium falciparum; Protozoan Proteins; Quinine; Selection, Genetic; Sequence Analysis, DNA; Verapamil | 1996 |
Verapamil inhibition of enzymatic product efflux leads to improved detection of beta-galactosidase activity in lacZ-transfected cells.
Topics: 3T3 Cells; alpha-Galactosidase; Animals; beta-Galactosidase; Cell Line; Chloroquine; Chromatography, High Pressure Liquid; Fibroblasts; Flow Cytometry; Fluoresceins; Galactosides; Gene Expression; Lac Operon; Lysosomes; Mice; Substrate Specificity; Transfection; Verapamil | 1997 |
Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Humans; Indolizines; Malaria, Falciparum; Phenethylamines; Plasmodium falciparum; Verapamil | 1998 |
High-level chloroquine resistance of Plasmodium berghei is associated with multiple drug resistance and loss of reversal by calcium antagonists.
Topics: Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Drug Synergism; Malaria; Mice; Nicardipine; Plasmodium berghei; Verapamil | 1998 |
Drug accumulation in the presence of the multidrug resistance pump: dissociation between verapamil accumulation and the action of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Daunorubicin; Drug Resistance, Multiple; Mice; Tumor Cells, Cultured; Verapamil; Vinblastine | 1997 |
Hepatic sequestration and modulation of the canalicular transport of the organic cation, daunorubicin, in the Rat.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Bile Canaliculi; Biological Transport; Bucladesine; Cations; Chloroquine; Daunorubicin; Kinetics; Liver; Macrolides; Male; Mitochondrial Proteins; Nocodazole; Rats; Rats, Wistar; Ribosomal Proteins; Saccharomyces cerevisiae Proteins; Taurocholic Acid; Verapamil | 1999 |
Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum.
Topics: Amiloride; Animals; Antimalarials; Bicarbonates; Biological Transport; Chloroquine; Erythrocyte Membrane; Erythrocytes; Hemin; Hemoglobins; Humans; Hydrogen-Ion Concentration; Kinetics; Leupeptins; Plasmodium falciparum; Sodium-Hydrogen Exchangers; Verapamil | 1999 |
Phenotypic and genotypic characteristics of recently adapted isolates of Plasmodium falciparum from Thailand.
Topics: Animals; Antimalarials; Blotting, Western; Chloroquine; DNA Fingerprinting; DNA, Protozoan; Drug Resistance; Electrophoresis, Agar Gel; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Penfluridol; Phenanthrenes; Phenotype; Plasmodium falciparum; Polymerase Chain Reaction; Quinine; Thailand; Verapamil | 1999 |
Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria.
Topics: Alkaloids; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Interactions; Drug Resistance; Malaria, Falciparum; Mice; Plasmodium falciparum; Plasmodium yoelii; Solubility; Verapamil | 2000 |
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.
Topics: Amino Acid Substitution; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Mefloquine; Mutation; Phenanthrenes; Plasmodium falciparum; Protozoan Proteins; Quinine; Sesquiterpenes; Verapamil | 2000 |
The effects of chloroquine and verapamil on digestive vacuolar pH of P. falciparum either sensitive or resistant to chloroquine.
Topics: Acridine Orange; Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Humans; Hydrogen-Ion Concentration; Microscopy, Fluorescence; Parasitic Sensitivity Tests; Photometry; Plasmodium falciparum; Vacuoles; Verapamil | 2000 |
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.
Topics: Amino Acid Sequence; Animals; Animals, Genetically Modified; Chloroquine; Digestive System; Drug Resistance; Exons; Humans; Membrane Proteins; Membrane Transport Proteins; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Recombinant Proteins; Tetrahydrofolate Dehydrogenase; Transfection; Vacuoles; Verapamil | 2000 |
Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum.
Topics: Acridine Orange; Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Drug Interactions; Drug Resistance; Fluorescence; Membrane Proteins; Membrane Transport Proteins; Molecular Conformation; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinidine; Quinine; Verapamil | 2002 |
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Genes, Protozoan; Haplotypes; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinine; Sesquiterpenes; Transfection; Verapamil | 2002 |
pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines.
Topics: Alleles; Amino Acid Substitution; Amino Acids; Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Codon; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Mutation; Philippines; Plasmodium falciparum; Protozoan Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Protozoan; Verapamil | 2003 |
Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Cell Line; Chloride Channels; Chloroquine; Drug Resistance; Drug Synergism; Hydrophobic and Hydrophilic Interactions; Ion Channels; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Transfection; Verapamil | 2003 |
Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH.
Topics: Acridine Orange; Alleles; Animals; Antimalarials; Chloroquine; Cytophotometry; Drug Resistance; Hydrogen-Ion Concentration; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Recombination, Genetic; Vacuoles; Verapamil | 2004 |
Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents.
Topics: Alanine; Alleles; Amantadine; Amino Acid Sequence; Amino Acid Substitution; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Genes, Protozoan; Haplotypes; Hemin; Membrane Proteins; Membrane Transport Proteins; Microsatellite Repeats; Molecular Sequence Data; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Point Mutation; Protein Structure, Secondary; Protozoan Proteins; Recombination, Genetic; Verapamil | 2004 |
Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Carrier Proteins; Chloroquine; Drug Resistance; Plasmodium falciparum; Substrate Specificity; Verapamil | 2004 |
Mutations in pfmdr1 modulate the sensitivity of Plasmodium falciparum to the intrinsic antiplasmodial activity of verapamil.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Chloroquine; Drug Resistance; Mutation; Plasmodium falciparum; Verapamil | 2005 |
Chemosensitizing action of cepharanthine against drug-resistant human malaria, Plasmodium falciparum.
Topics: Alkaloids; Animals; Benzylisoquinolines; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Antagonism; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Inhibitory Concentration 50; KB Cells; Malaria, Falciparum; Male; Mice; Parasitemia; Parasitic Sensitivity Tests; Plasmodium berghei; Quinine; Verapamil | 2005 |
A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Hemin; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Verapamil | 2005 |
The effects of alpha1-acid glycoprotein on the reversal of chloroquine resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Chlorpheniramine; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Enzyme Inhibitors; Histamine H1 Antagonists; Orosomucoid; Plasmodium falciparum; Promethazine; Verapamil | 2006 |
A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites.
Topics: Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Drug Resistance; Enzyme Inhibitors; Hydrogen; Hydrogen-Ion Concentration; Macrolides; Permeability; Plasmodium falciparum; Proton Pumps; Vacuoles; Verapamil | 2008 |
Chloroquine transport via the malaria parasite's chloroquine resistance transporter.
Topics: Amino Acid Sequence; Animals; Antimalarials; Biological Transport; Cell Membrane; Chloroquine; Drug Resistance; Hydrogen-Ion Concentration; Membrane Potentials; Membrane Transport Proteins; Molecular Sequence Data; Mutant Proteins; Mutation; Oligopeptides; Oocytes; Plasmodium falciparum; Protozoan Proteins; Recombinant Proteins; Verapamil; Xenopus laevis | 2009 |
Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross.
Topics: Antimalarials; Chloroquine; Drug Resistance; Gene Dosage; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Quantitative Trait Loci; Verapamil | 2010 |
A partial convergence in action of methylene blue and artemisinins: antagonism with chloroquine, a reversal with verapamil, and an insight into the antimalarial activity of chloroquine.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Synergism; Flavin-Adenine Dinucleotide; Homeostasis; Humans; Malaria; Methylene Blue; Oxidation-Reduction; Verapamil | 2011 |
Functional characterization of the Plasmodium falciparum chloroquine-resistance transporter (PfCRT) in transformed Dictyostelium discoideum vesicles.
Topics: Adenosine Triphosphate; Ammonia; Animals; Antimalarials; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line, Transformed; Chloroquine; Cytoplasmic Vesicles; Dictyostelium; Hydrogen-Ion Concentration; Ionophores; Macrolides; Membrane Potentials; Membrane Transport Proteins; Phenotype; Plasmodium falciparum; Potassium; Protozoan Proteins; Valinomycin; Verapamil | 2012 |
Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
Topics: Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chloroquine; Doxycycline; Drug Resistance, Neoplasm; Humans; Mefloquine; Primaquine; Verapamil; Vinblastine | 2013 |
Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assay.
Topics: Adenosine Triphosphate; Animals; Biomarkers; Boron Compounds; Chloroquine; DNA Copy Number Variations; Drug Resistance; Fluorescent Dyes; Genes, Protozoan; Inhibitory Concentration 50; Mibefradil; Microsomes; Molecular Probe Techniques; Parasites; Plasmodium falciparum; Polymorphism, Genetic; Reproducibility of Results; Verapamil | 2014 |
Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites.
Topics: Animals; Antimalarials; Binding Sites; Binding, Competitive; Biological Transport; Cells, Cultured; Chloroquine; Drug Resistance; Female; Hydrogen-Ion Concentration; Kinetics; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Quinidine; Quinine; Verapamil; Xenopus laevis | 2014 |
Simultaneous administration of 2-aminoethyl diphenylborinate and chloroquine reverses chloroquine resistance in malaria parasites.
Topics: Animals; Antimalarials; Chloroquine; Female; Inhibitory Concentration 50; Malaria; Mice; Mice, Inbred ICR; Plasmodium falciparum; Verapamil | 2015 |
Plasmodium falciparum chloroquine resistance transporter is a H+-coupled polyspecific nutrient and drug exporter.
Topics: Amino Acids; Biological Transport; Chloroquine; Drug Resistance; Membrane Transport Proteins; Protons; Protozoan Proteins; Tetraethylammonium; Verapamil | 2015 |
Verapamil treatment induces cytoprotective autophagy by modulating cellular metabolism.
Topics: Antimalarials; Antineoplastic Agents; Autophagosomes; Autophagy; Autophagy-Related Protein 5; Autophagy-Related Protein 7; Biomarkers; Calcium Channel Blockers; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chloroquine; CRISPR-Cas Systems; Cytoprotection; Energy Metabolism; Glycolysis; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Microscopy, Electron, Transmission; Neoplasms; Verapamil | 2017 |
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine.
Topics: Animals; Antimalarials; Cambodia; Cell Shape; Chloroquine; Drug Resistance; Gene Dosage; Gene Editing; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Parasites; Plasmodium falciparum; Protozoan Proteins; Quinolines; Verapamil | 2018 |